| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |